BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 17, 2011
View Archived Issues
New HIF prolyl hydroxylase inhibitors reported
Read More
Serotonin 5-HT4 receptor agonist DA-6886 enhances colonic transit in mice
Read More
Merck & Co. reports key developments of first quarter of 2011
Read More
DM-CocE protects against and reverses acute cocaine toxicity in rats and primates
Read More
Bivalent vaccine CP-5/EPA induces protective antibodies in preclinical studies
Read More
Lamellar body mimetic LMS-611 reduces bacterial biofilms in combination with antibiotics
Read More
OPC-34712 improves symptoms of depression as adjunctive to standard antidepressant therapy
Read More
Anacor Pharmaceuticals present new antiprotozoal agents
Read More
Novel gamma-secretase modulators prepared by Pfizer
Read More
IntelGenx replies to FDA complete response letter on CPI-300
Read More
Tranzyme Pharma discloses new serine protease inhibitors
Read More
Prexa Pharmaceuticals raises funds to advance PRX-12251
Read More
Merus Labs acquires Vancocin from Iroko Pharmaceuticals
Read More
Korean scientists claim new protein kinase inhibitors
Read More
Glenmark Pharmaceuticals grants sanofi-aventis license for GBR-500
Read More
Swissmedic approves Eisai's Halaven for breast cancer
Read More
Teijin Pharma to launch Feburic in Japan for hyperuricemia
Read More
CEI to be site for phase I/II MA-09-HRPE trial in Stargardt's macular dystrophy
Read More
Merck & Co.'s acquisition of Inspire Pharmaceuticals completed
Read More
Ark Therapeutics presents update on drug development pipeline
Read More
IDMC recommends continuation of Thallion's phase II trial of ShigamAb
Read More
Astellas acquires Perseid Therapeutics from Maxygen
Read More
Crizotinib NDA filed in Japan for ALK-positive NSCLC and accepted for priority review in U.S.
Read More
UCB profiles events of first quarter 2011
Read More
Promising phase II data reported on CT-011 in diffuse large B-cell lymphoma
Read More